Although this experimental study does not directly indicate an increased risk of developing T2DM associated with MCL1, it suggests that targeting the MCL1 gene could be beneficial in preventing the progression of diabetes, potentially offering new avenues for the treatment of diabetes [44]. This evidence concerns the gene MCL1 and type 2 diabetes mellitus.